Our Team
Riyadh Rehani, PhD: Founder and CEO
Dr. Riyadh Rehani, a seasoned pharmaceutical executive, boasts an illustrious career that stretches around the world. Recognized for his invaluable leadership as the Senior Advisor at Photonamic GmbH & Co. KG, Germany, and as President of SBI Pharma in the MENA region, Dr. Rehani's work prominently features the global promotion and regulatory successes of various pharmaceutical products. His tenure is marked by innovative drug developments, strategic corporate advisory roles, and spearheading global initiatives for an array of pharmaceutical and supplement based products. In addition to his corporate achievements, Dr. Rehani has left an indelible mark on the academic realm as an Honorary Professor at RCSI Bahrain, dedicated to training the next generation of medical professionals. Today, he offers his vast expertise as a senior consultant, assisting organizations in navigating the complexities of the pharmaceutical and healthcare sectors.
Pharma and Device Development Executive with 25 years of broad industry experience. Excellent strategic and tactical knowledge regarding clinical development operations across all functions. Strong ability to develop and align regulatory and scientific teams with corporate objectives to achieve business results. Multiple successful drug and device program approvals.
Specialties: Strategies for operational innovation and value creation incorporating technology; risk management, quality & compliance, due diligence, and business/investor development support.
Greg Ambra, MS, MBA: Independent Consultant Clinical Development
Peter Rehani: Artificial Intelligence Consultant
Peter Rehani is an experienced Artificial Intelligence (AI) engineer, with a background in everything from gene regulatory networks to AI based EKG analysis to single cell metabolic imaging and analysis. He obtained his Bachelors of Science from the University of Wisconsin, Madison with a triple major in Neurobiology, Computer Science, and Applied Mathematics with a Bioinformatics focus. He has worked across domains of machine learning and artificial intelligence, and is excited to bring this expertise to a new venture of advancing healthcare technology.